Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company OncoMed Pharmaceuticals Inc.
Description mAb targeting R-Spondin 3 (RSPO3)
Molecular Target R-Spondin 3 (RSPO3)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today